What is next in sepsis: Current trials in sepsis

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 8, 2012, Pages 859-862

  Artigas, Antonio ^a,b   Niederman, Michael S ^c,d   Torres, Antoni ^e   Carlet, Jean ^f  

^a HOSPITAL DE SABADELL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c WINTHROP UNIVERSITY HOSPITAL   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e UNIVERSITY OF BARCELONA   (Spain)

^f Intensive Care Specialist   (France)

Author keywords

immunotherapy; sepsis; septic shock; severe infections

Indexed keywords

ASCORBIC ACID; CARNITINE; CITRULLINE; CYTOFAB; ERITORAN; RESATORVID; SELENIUM; STATIN; TALACTOFERRIN;

CRITICALLY ILL PATIENT; DIET SUPPLEMENTATION; DISEASE SEVERITY; HEMADSORPTION; HEMODIALYSIS; HEMODYNAMIC MONITORING; HEMOFILTRATION; HEMOPERFUSION; HIGH RISK PATIENT; HUMAN; MORTALITY; PLASMA CLEARANCE; PROSPECTIVE STUDY; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ULTRAFILTRATION;

ALBUMINS; APOPTOSIS; BACTERIA; CLINICAL TRIALS AS TOPIC; CRITICAL ILLNESS; DISEASE MANAGEMENT; DRUG DISCOVERY; HUMANS; IMMUNOMODULATION; INFLAMMATION; INTENSIVE CARE UNITS; SEPSIS; SIGNAL TRANSDUCTION;

EID: 84867074543     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.82     Document Type: Review

References (15)

1. Ranieri MV, Thompson TB, Barie PHS et al. Drotrecogin ? (activated) in adults with septic shock. N. Engl. J. Med. 366(22), 2055-2064 (2012).
2. Janda S, Young A, Fitzgerald JM, Etminan M, Swiston J. The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis. J. Crit. Care 25(4), 656.e7-656.e22 (2010).
3. Cruz DN, Antonelli M, Fumagalli R et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301(23), 2445-2452 (2009).
4. Novelli G, Ferretti G, Poli L et al. Clinical results of treatment of postsurgical endotoxinmediated sepsis with polymyxin-B direct hemoperfusion. Transplant. Proc. 42(4), 1021-1024 (2010).
5. Tidswell M, Tillis W, Larosa SP et al.; Eritoran Sepsis Study Group. Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis. Crit. Care Med. 38(1), 72-83 (2010).
6. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348(2), 138-150 (2003).
7. Cohen J. The immunopathogenesis of sepsis. Nature 420(6917), 885-891 (2002).
8. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N. Engl. J. Med. 364(7), 656-665 (2011).
9. Mei SH, Haitsma JJ, Dos Santos CC et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am. J. Respir. Crit. Care Med. 182(8), 1047-1057 (2010).
10. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N. Engl. J. Med. 350, 2247-2256 (2004).
11. Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R; The SAFE Study Investigators. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 37, 86-96 (2011).
12. Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit. Care Med. 39(2), 386-391 (2011).
13. Monnet X, Letierce A, Hamzaoui O et al. Arterial pressure allows monitoring the changes in cardiac output induced by volume expansion but not by norepinephrine. Crit. Care Med. 39(6), 1394-1399 (2011).
14. Garrouste-Orgeas M, Timsit JF, Vesin A et al.; OUTCOMEREA Study Group. Selected medical errors in the intensive care unit: results of the IATROREF study: parts I and II. Am. J. Respir. Crit. Care Med. 181(2), 134-142 (2010).
15. Levy MM, Dellinger RP, Townsend SR et al.; Surviving Sepsis Campaign. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit. Care Med. 38(2), 367-374 (2010).